[1]
|
Wolfgang, C.L., Herman, J.M., Laheru, D.A., Klein, A.P., Erdek, M.A., Fishman, E.K., et al. (2013) Recent Progress in Pancreatic Cancer. CA: A Cancer Journal for Clinicians, 63, 318-348. https://doi.org/10.3322/caac.21190
|
[2]
|
Zhu, H., Li, T., Du, Y. and Li, M. (2018) Pancreatic Cancer: Challenges and Opportunities. BMC Medicine, 16, Article No. 214. https://doi.org/10.1186/s12916-018-1215-3
|
[3]
|
Zhou, B., Xu, J.W., Cheng, Y.G., Gao, J.Y., Hu, S.Y., Wang, L., et al. (2017) Early Detection of Pancreatic Cancer: Where Are We Now and Where Are We Going? International Journal of Cancer, 141, 231-241. https://doi.org/10.1002/ijc.30670
|
[4]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. https://doi.org/10.3322/caac.21654
|
[5]
|
McGuigan, A., Kelly, P., Turkington, R.C., Jones, C., Coleman, H.G. and McCain, R.S. (2018) Pancreatic Cancer: A Review of Clinical Diagnosis, Epidemiology, Treatment and Outcomes. World Journal of Gastroenterology, 24, 4846-4861. https://doi.org/10.3748/wjg.v24.i43.4846
|
[6]
|
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C.D., Biankin, A.V., et al. (2016) Pancreatic Cancer. Nature Reviews Disease Primers, 2, Article No. 16022. https://doi.org/10.1038/nrdp.2016.22
|
[7]
|
Hsueh, C.T. (2011) Pancreatic Cancer: Current Standards, Research Updates and Future Directions. Journal of Gastrointestinal Oncology, 2, 123-125.
|
[8]
|
Fensterer, H., Schade-Brittinger, C., Müller, H.H., Tebbe, S., Fass, J., Lindig, U., et al. (2013) Multicenter Phase II Trial to Investigate Safety and Efficacy of Gemcitabine Combined with Cetuximab as Adjuvant Therapy in Pancreatic Cancer (ATIP). Annals of Oncology: Official Journal of the European Society for Medical Oncology, 24, 2576-2581. https://doi.org/10.1093/annonc/mdt270
|
[9]
|
Wang, Y., Hu, G.F., Zhang, Q.Q., Tang, N., Guo, J., Liu, L.Y., et al. (2016) Efficacy and Safety of Gemcitabine plus Erlotinib for Locally Advanced or Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis. Drug Design, Development and Therapy, 10, 1961-1972. https://doi.org/10.2147/DDDT.S105442
|
[10]
|
Gao, C., Wu, X., Yan, Y., Meng, L., Shan, D., Li, Y., et al. (2016) Sensitization of Radiation or Gemcitabine-Based Chemoradiation Therapeutic Effect by Nimotuzumab in Pancreatic Cancer Cells. Technology in Cancer Research & Treatment, 15, 446-452. https://doi.org/10.1177/1533034615585209
|
[11]
|
Ogitani, Y., Aida, T., Hagihara, K., Yamaguchi, J., Ishii, C., Harada, N., et al. (2016) DS-8201a, a Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 22, 5097-5108. https://doi.org/10.1158/1078-0432.CCR-15-2822
|
[12]
|
Strosberg, J.R., Chan, J.A., Ryan, D.P., Meyerhardt, J.A., Fuchs, C.S., Abrams, T., et al. (2013) A Multi-Institutional, Phase II Open-Label Study of Ganitumab (AMG 479) in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors. Endocrine-Related Cancer, 20, 383-390. https://doi.org/10.1530/ERC-12-0390
|
[13]
|
Bahrami, A., Khazaei, M., Bagherieh, F., Ghayour-Mobarhan, M., Maftouh, M., Hassanian, S.M., et al. (2017) Targeting Stroma in Pancreatic Cancer: Promises and Failures of Targeted Therapies. Journal of Cellular Physiology, 232, 2931-2937. https://doi.org/10.1002/jcp.25798
|
[14]
|
Okazaki, M., Takeshita, S., Kawai, S., Kikuno, R., Tsujimura, A., Kudo, A., et al. (1994) Molecular Cloning and Characterization of OB-Cadherin, a New Member of Cadherin Family Expressed in Osteoblasts. The Journal of Biological Chemistry, 269, 12092-12098. https://doi.org/10.1016/S0021-9258(17)32685-6
|
[15]
|
Kremmidiotis, G., Baker, E., Crawford, J., Eyre, H.J., Nahmias, J. and Callen, D.F. (1998) Localization of Human Cadherin Genes to Chromosome Regions Exhibiting Cancer-Related Loss of Heterozygosity. Genomics, 49, 467-471. https://doi.org/10.1006/geno.1998.5281
|
[16]
|
Van Roy, F. (2014) Beyond E-Cadherin: Roles of Other Cadherin Superfamily Members in Cancer. Nature Reviews Cancer, 14, 121-134. https://doi.org/10.1038/nrc3647
|
[17]
|
Takeichi, M. (1995) Morphogenetic Roles of Classic Cadherins. Current Opinion in Cell Biology, 7, 619-627. https://doi.org/10.1016/0955-0674(95)80102-2
|
[18]
|
Hoffmann, I. and Balling, R. (1995) Cloning and Expression Analysis of a Novel Mesodermally Expressed Cadherin. Developmental Biology, 169, 337-346. https://doi.org/10.1006/dbio.1995.1148
|
[19]
|
Wheelock, M.J. and Johnson, K.R. (2003) Cadherins as Modulators of Cellular Phenotype. Annual Review of Cell and Developmental Biology, 19, 207-235. https://doi.org/10.1146/annurev.cellbio.19.011102.111135
|
[20]
|
Aghdassi, A., Sendler, M., Guenther, A., Mayerle, J., Behn, C.O., Heidecke, C.D., et al. (2012) Recruitment of Histone Deacetylases HDAC1 and HDAC2 by the Transcriptional Repressor ZEB1 Downregulates E-Cadherin Expression in Pancreatic Cancer. Gut, 61, 439-448. https://doi.org/10.1136/gutjnl-2011-300060
|
[21]
|
Cavallaro, U. and Dejana, E. (2011) Adhesion Molecule Signalling: Not Always a Sticky Business. Nature Reviews Molecular Cell Biology, 12, 189-197. https://doi.org/10.1038/nrm3068
|
[22]
|
Niessen, C.M. and Gumbiner, B.M. (2002) Cadherin-Mediated Cell Sorting Not Determined by Binding or Adhesion Specificity. The Journal of Cell Biology, 156, 389-399. https://doi.org/10.1083/jcb.200108040
|
[23]
|
Angst, B.D., Marcozzi, C. and Magee, A.I. (2001) The Cadherin Superfamily: Diversity in Form and Function. Journal of Cell Science, 114, 629-641. https://doi.org/10.1242/jcs.114.4.629
|
[24]
|
Madarampalli, B., Watts, G.F.M., Panipinto, P.M., Nguygen, H.N., Brenner, M.B. and Noss, E.H. (2019) Interactions between Cadherin-11 and Platelet-Derived Growth Factor Receptor-Alpha Signaling Link Cell Adhesion and Proliferation. Biochimica et Biophysica Acta Molecular Basis of Disease, 1865, 1516-1524. https://doi.org/10.1016/j.bbadis.2019.03.001
|
[25]
|
Tang, Z., Li, C., Kang, B., Gao, G., Li, C. and Zhang, Z. (2017) GEPIA: A Web Server for Cancer and Normal Gene Expression Profiling and Interactive Analyses. Nucleic Acids Research, 45, W98-W102. https://doi.org/10.1093/nar/gkx247
|
[26]
|
Ruan, W., Pan, R., Shen, X., Nie, Y. and Wu, Y. (2019) CDH11 Promotes Liver Fibrosis via Activation of Hepatic Stellate Cells. Biochemical and Biophysical Research Communications, 508, 543-549. https://doi.org/10.1016/j.bbrc.2018.11.153
|
[27]
|
Birtolo, C., Pham, H., Morvaridi, S., Chheda, C., Go, V.L., Ptasznik, A., et al. (2017) Cadherin-11 Is a Cell Surface Marker Up-Regulated in Activated Pancreatic Stellate Cells and Is Involved in Pancreatic Cancer Cell Migration. The American Journal of Pathology, 187, 146-155. https://doi.org/10.1016/j.ajpath.2016.09.012
|
[28]
|
Yamauchi, M., Barker, T.H., Gibbons, D.L. and Kurie, J.M. (2018) The Fibrotic Tumor Stroma. The Journal of Clinical Investigation, 128, 16-25. https://doi.org/10.1172/JCI93554
|
[29]
|
Ferdek, P.E. and Jakubowska, M.A. (2017) Biology of Pancreatic Stellate Cells—More than Just Pancreatic Cancer. Pflugers Archiv: European Journal of Physiology, 469, 1039-1050. https://doi.org/10.1007/s00424-017-1968-0
|
[30]
|
Lotvall, J., Hill, A.F., Hochberg, F., Buzás, E.I., Di Vizio, D., et al. (2014) Minimal Experimental Requirements for Definition of Extracellular Vesicles and Their Functions: A Position Statement from the International Society for Extracellular Vesicles. Journal of Extracellular Vesicles, 3, Article No. 26913. https://doi.org/10.3402/jev.v3.26913
|
[31]
|
Takikawa, T., Masamune, A., Yoshida, N., Hamada, S., Kogure, T. and Shimosegawa, T. (2017) Exosomes Derived from Pancreatic Stellate Cells: MicroRNA Signature and Effects on Pancreatic Cancer Cells. Pancreas, 46, 19-27. https://doi.org/10.1097/MPA.0000000000000722
|
[32]
|
Chronopoulos, A., Robinson, B., Sarper, M., Cortes, E., Auernheimer, V., Lachowski, D., et al. (2016) ATRA Mechanically Reprograms Pancreatic Stellate Cells to Suppress Matrix Remodelling and Inhibit Cancer Cell Invasion. Nature Communications, 7, Article No. 12630. https://doi.org/10.1038/ncomms12630
|
[33]
|
Zhu, Z., Kleeff, J., Kayed, H., Wang, L., Korc, M., Büchler, M.W., et al. (2002) Nerve Growth Factor and Enhancement of Proliferation, Invasion, and Tumorigenicity of Pancreatic Cancer Cells. Molecular Carcinogenesis, 35, 138-147. https://doi.org/10.1002/mc.10083
|
[34]
|
Yao, Z., Yuan, T., Wang, H., Yao, S., Zhao, Y., Liu, Y., et al. (2017) MMP-2 Together with MMP-9 Overexpression Correlated with Lymph Node Metastasis and Poor Prognosis in Early Gastric Carcinoma. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 39. https://doi.org/10.1177/1010428317700411
|
[35]
|
Nan, L., Qin, T., Xiao, Y., Qian, W., Li, J., Wang, Z., et al. (2019) Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway. Cell Transplantation, 28, 1289-1298. https://doi.org/10.1177/0963689719851772
|
[36]
|
Peran, I., Dakshanamurthy, S., McCoy, M.D., Mavropoulos, A., Allo, B., Sebastian, A., et al. (2021) Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice. Gastroenterology, 160, 1359-1372.e1313. https://doi.org/10.1053/j.gastro.2020.11.044
|